Archive for the ‘fuad’ Category
Emergent BioSolutions to Release Fourth Quarter and Full Year 2011 Financial Results and Conduct a Conference Call on March 8, 2012
ROCKVILLE, Md.–(BUSINESS WIRE)–Jan. 30, 2012– Emergent BioSolutions Inc. (NYSE: EBS) announced today that it will report financial results for the fourth quarter and full year 2011 on Thursday, March 8, 2012, after market close.
Company management will host a conference call at 5:00 pm Eastern on March 8, 2012 to discuss the financial results for the [...]
February 3, 2012
Tags: Business Wire, Conference call, Emergent BioSolutions, fuad el-hibri, New York Stock Exchange Posted in: Chief executive officer, El-Hibri, Investors, Revenue, fuad 
No Comments
Emergent BioSolutions to Present Today at Needham & Company Healthcare Conference
Emergent BioSolutions Inc. (NYSE: EBS) will be webcasting its presentation at the 10th Annual Needham & Company Healthcare Conference in New York on Tuesday, April 5, 2011 at 8:00 AM Eastern. During the presentation, a member of the company’s senior management team will provide a corporate overview, which may include a discussion of [...]
April 5, 2011
Tags: Business, Chief executive officer, Emergent BioSolutions, fuad el-hibri, Needham & Company Healthcare Conference Posted in: Board of Directors, El-Hibri, Emergent BioSolutions, Healthcare Conference, fuad, fuad el-hibri No Comments
Emergent BioSolutions Observes World TB Day Launches “OETC: Endeavor to End Tuberculosis,” a video to raise public awareness of TB
ROCKVILLE, Md., Mar 24, 2011 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today released the following statement in observance of World TB Day.
The World TB Day 2011 campaign, “On the move against TB: Transforming the fight towards elimination,” challenges us to undertake the fight [...]
March 25, 2011
Tags: Aeras Global TB Foundation, fuad el-hibri, Tuberculosis, World Health Organization, World TB Day Posted in: Emergent BioSolutions, TB, World TB Day, fuad, fuad el-hibri No Comments
CEO took roundabout path to Emergent
By Marjorie Censer
Monday, January 3, 2011
Fuad El-Hibri has lived in all sorts of exotic locales, working for Citicorp in Saudi Arabia, consulting for Booz Allen Hamilton in Indonesia and establishing mobile telecommunications businesses in Russia, Venezuela and El Salvador.
But getting started in his current position as chief executive of Rockville-based pharmaceutical company Emergent BioSolutions took [...]
January 7, 2011
Tags: Chief executive officer, Department of Health and Human Services, El-Hibri, Emergent BioSolutions Inc., entrepreneur, Rockville Posted in: Biosolutions, Business, CEO, Department of Health and Human Services, El-Hibri, Emergent BioSolutions, Research and development, Trubion Pharmaceuticals, Yale University, fuad, fuad el-hibri No Comments
Emergent BioSolutions Inc., Q2 2009 Earnings Call Transcript
Emergent BioSolutions Inc., (EBS)
Q2 2009 Earnings Call
August 6, 2009 5:00 pm ET
Executives
Robert G. Burrows – Vice President, Investor Relations
Fuad El-Hibri – Chairman of the Board, Chief Executive Officer
R. Don Elsey – Chief Financial Officer
Daniel J. Abdun-Nabi – President, Chief Operating Officer
W. James Jackson, Ph.D. – Senior Vice President and Chief Scientific Officer
Analysts
Eric Schmidt [...]
August 14, 2009
Tags: Business, Chairman, Chief executive officer, Chief financial officer, Chief operating officer, Emergent BioSolutions, finance, fuad el-hibri, Investor relations, Shareholders, US government, Vice president Posted in: Board of Directors, CEO, Emergent BioSolutions, Management, Shareholders, fuad, fuad el-hibri No Comments